ENVERIC BIOSCIENCES, INC. Effective Tax Rate
ENVERIC BIOSCIENCES, INC. (ENVB) reported Effective Tax Rate of 0.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-27
- ENVERIC BIOSCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2024 was 0.10%, a 50.00% decline from fiscal 2023.
- ENVERIC BIOSCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2023 was 0.20%.
- ENVERIC BIOSCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2022 was -7.40%.
- ENVERIC BIOSCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2021 was -13.30%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.10% 10-K · filed 2026-03-27 | |
| 2023-12-31 | 0.20% 10-K · filed 2025-03-28 | |
| 2022-12-31 | -7.40% 10-K · filed 2024-03-26 | |
| 2021-12-31 | -13.30% 10-K/A · filed 2023-06-09 | 13.30% 10-K · filed 2022-03-31 |
| 2020-12-31 | 0.00% 10-K · filed 2022-03-31 | |
| 2019-12-31 | 0.00% 10-K · filed 2021-04-01 | 21.00% 10-K · filed 2020-03-25 |
| 2018-12-31 | 21.00% 10-K · filed 2020-03-25 | |
| 2017-12-31 | 21.00% 10-K · filed 2019-03-26 | |
| 2016-12-31 | 21.00% 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |